Deciphering the Cellular Targets of Bioactive Compounds Using a Chloroalkane Capture Tag

ACS Chemical Biology

Volumn 10, Issue 10, 2015, Pages 2316-2324

  Friedman Ohana, Rachel ^a   Kirkland, Thomas A ^b   Woodroofe, Carolyn C ^b   Levin, Sergiy ^b   Uyeda, H Tetsuo ^b   Otto, Paul ^a   Hurst, Robin ^a   Robers, Matthew B ^a   Zimmerman, Kris ^a   Encell, Lance P ^a   Wood, Keith V ^a  

^a PROMEGA CORPORATION   (United States)

^b Promega Biosciences LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKANE DERIVATIVE; CHLORINE DERIVATIVE; DASATINIB; DORAMAPIMOD; HISTONE DEACETYLASE; VORINOSTAT; ALKANE; CHLORINE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; PROTEIN BINDING;

ANALYTIC METHOD; ARTICLE; DRUG SCREENING; ENERGY TRANSFER; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; LIQUID CHROMATOGRAPHY; LYSIS; PHENOTYPE; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; CHEMICAL ANALYSIS; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG EFFECTS; HEK293 CELL LINE; PROCEDURES;

ALKANES; CHEMISTRY TECHNIQUES, ANALYTICAL; CHLORINE; CHROMATOGRAPHY, LIQUID; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; HEK293 CELLS; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; PROTEIN BINDING;

EID: 84944790595     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/acschembio.5b00351     Document Type: Article

References (40)

1. Gashaw, I., Ellinghaus, P., Sommer, A., and Asadullah, K. (2011) What makes a good drug target? Drug Discovery Today 16, 1037-1043 10.1016/j.drudis.2011.09.007
2. Swinney, D. C. and Anthony, J. (2011) How were new medicines discovered? Nat. Rev. Drug Discovery 10, 507-519 10.1038/nrd3480
3. Bantscheff, M. and Drewes, G. (2012) Chemoproteomic approaches to drug target identification and drug profiling Bioorg. Med. Chem. 20, 1973-1978 10.1016/j.bmc.2011.11.003
4. Cisar, J. S. and Cravatt, B. F. (2012) Fully functionalized small-molecule probes for integrated phenotypic screening and target identification J. Am. Chem. Soc. 134, 10385-10388 10.1021/ja304213w
5. Leslie, B. J. and Hergenrother, P. J. (2008) Identification of the cellular targets of bioactive small organic molecules using affinity reagents Chem. Soc. Rev. 37, 1347-1360 10.1039/b702942j
6. Mackinnon, A. L. and Taunton, J. (2009) Target Identification by Diazirine Photo-Cross-linking and Click Chemistry Curr. Protoc. Chem. Biol. 1, 55-73 10.1002/9780470559277.ch090167
7. Rix, U. and Superti-Furga, G. (2009) Target profiling of small molecules by chemical proteomics Nat. Chem. Biol. 5, 616-624 10.1038/nchembio.216
8. Sleno, L. and Emili, A. (2008) Proteomic methods for drug target discovery Curr. Opin. Chem. Biol. 12, 46-54 10.1016/j.cbpa.2008.01.022
9. Sato, S., Murata, A., Shirakawa, T., and Uesugi, M. (2010) Biochemical target isolation for novices: affinity-based strategies Chem. Biol. 17, 616-623 10.1016/j.chembiol.2010.05.015
10. Ziegler, S., Pries, V., Hedberg, C., and Waldmann, H. (2013) Target identification for small bioactive molecules: finding the needle in the haystack Angew. Chem., Int. Ed. 52, 2744-2792 10.1002/anie.201208749
11. Bantscheff, M., Scholten, A., and Heck, A. J. (2009) Revealing promiscuous drug-target interactions by chemical proteomics Drug Discovery Today 14, 1021-1029 10.1016/j.drudis.2009.07.001
12. Salisbury, C. M. and Cravatt, B. F. (2008) Optimization of activity-based probes for proteomic profiling of histone deacetylase complexes J. Am. Chem. Soc. 130, 2184-2194 10.1021/ja074138u
13. Su, Y., Ge, J., Zhu, B., Zheng, Y. G., Zhu, Q., and Yao, S. Q. (2013) Target identification of biologically active small molecules via in situ methods Curr. Opin. Chem. Biol. 17, 768-775 10.1016/j.cbpa.2013.06.005
14. Salisbury, C. M. and Cravatt, B. F. (2007) Activity-based probes for proteomic profiling of histone deacetylase complexes Proc. Natl. Acad. Sci. U. S. A. 104, 1171-1176 10.1073/pnas.0608659104
15. Kawamura, A., Hindi, S., Mihai, D. M., James, L., and Aminova, O. (2008) Binding is not enough: flexibility is needed for photocrosslinking of Lck kinase by benzophenone photoligands Bioorg. Med. Chem. 16, 8824-8829 10.1016/j.bmc.2008.08.077
16. Sakurai, K., Ozawa, S., Yamada, R., Yasui, T., and Mizuno, S. (2014) Comparison of the reactivity of carbohydrate photoaffinity probes with different photoreactive groups ChemBioChem 15, 1399-1403 10.1002/cbic.201402051
17. Duckworth, B. P., Xu, J., Taton, T. A., Guo, A., and Distefano, M. D. (2006) Site-specific, covalent attachment of proteins to a solid surface Bioconjugate Chem. 17, 967-974 10.1021/bc060125e
18. Speers, A. E. and Cravatt, B. F. (2004) Profiling enzyme activities in vivo using click chemistry methods Chem. Biol. 11, 535-546 10.1016/j.chembiol.2004.03.012
19. Encell, L. P., Friedman Ohana, R., Zimmerman, K., Otto, P., Vidugiris, G., Wood, M. G., Los, G. V., McDougall, M. G., Zimprich, C., Karassina, N., Learish, R. D., Hurst, R., Hartnett, J., Wheeler, S., Stecha, P., English, J., Zhao, K., Mendez, J., Benink, H. A., Murphy, N., Daniels, D. L., Slater, M. R., Urh, M., Darzins, A., Klaubert, D. H., Bulleit, R. F., and Wood, K. V. (2012) Development of a dehalogenase-based protein fusion tag capable of rapid, selective and covalent attachment to customizable ligands Curr. Chem. Genomics 6, 55-71 10.2174/1875397301206010055
20. Los, G. V., Encell, L. P., McDougall, M. G., Hartzell, D. D., Karassina, N., Zimprich, C., Wood, M. G., Learish, R., Ohana, R. F., Urh, M., Simpson, D., Mendez, J., Zimmerman, K., Otto, P., Vidugiris, G., Zhu, J., Darzins, A., Klaubert, D. H., Bulleit, R. F., and Wood, K. V. (2008) HaloTag: a novel protein labeling technology for cell imaging and protein analysis ACS Chem. Biol. 3, 373-382 10.1021/cb800025k
21. Martinez Molina, D., Jafari, R., Ignatushchenko, M., Seki, T., Larsson, E. A., Dan, C., Sreekumar, L., Cao, Y., and Nordlund, P. (2013) Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay Science 341, 84-87 10.1126/science.1233606
22. Xu, Y., Piston, D. W., and Johnson, C. H. (1999) A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins Proc. Natl. Acad. Sci. U. S. A. 96, 151-156 10.1073/pnas.96.1.151
23. Hall, M. P., Unch, J., Binkowski, B. F., Valley, M. P., Butler, B. L., Wood, M. G., Otto, P., Zimmerman, K., Vidugiris, G., Machleidt, T., Robers, M. B., Benink, H. A., Eggers, C. T., Slater, M. R., Meisenheimer, P. L., Klaubert, D. H., Fan, F., Encell, L. P., and Wood, K. V. (2012) Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate ACS Chem. Biol. 7, 1848-1857 10.1021/cb3002478
24. Stoddart, L. A., Johnstone, E. K. M., Wheal, A. J., Goulding, J., Robers, M. B., Machleidt, T., Wood, K. V., Hill, S. J., and Pfleger, K. D. G. (2015) Application of BRET to monitor ligand binding to GPCRs Nat. Methods 12, 661-663 10.1038/nmeth.3398
25. Bradner, J. E., West, N., Grachan, M. L., Greenberg, E. F., Haggarty, S. J., Warnow, T., and Mazitschek, R. (2010) Chemical phylogenetics of histone deacetylases Nat. Chem. Biol. 6, 238-243 10.1038/nchembio.313
26. Dokmanovic, M., Clarke, C., and Marks, P. A. (2007) Histone deacetylase inhibitors: overview and perspectives Mol. Cancer Res. 5, 981-989 10.1158/1541-7786.MCR-07-0324
27. Hockly, E., Richon, V. M., Woodman, B., Smith, D. L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P. A., Steffan, J. S., Marsh, J. L., Thompson, L. M., Lewis, C. M., Marks, P. A., and Bates, G. P. (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington;s disease Proc. Natl. Acad. Sci. U. S. A. 100, 2041-2046 10.1073/pnas.0437870100
28. Liu, H., Kuhn, C., Feru, F., Jacques, S. L., Deshmukh, G. D., Ye, P., Rennie, G. R., Johnson, T., Kazmirski, S., Low, S., Coli, R., Ding, Y. H., Cheng, A. C., Tecle, H., English, J. M., Stanton, R., and Wu, J. C. (2010) Enhanced selectivity profile of pyrazole-urea based DFG-out p38alpha inhibitors Bioorg. Med. Chem. Lett. 20, 4885-4891 10.1016/j.bmcl.2010.06.073
29. Rix, U., Hantschel, O., Durnberger, G., Remsing Rix, L. L., Planyavsky, M., Fernbach, N. V., Kaupe, I., Bennett, K. L., Valent, P., Colinge, J., Kocher, T., and Superti-Furga, G. (2007) Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets Blood 110, 4055-4063 10.1182/blood-2007-07-102061
30. Gruenbaum, L. M., Schwartz, R., Woska, J. R., Jr., DeLeon, R. P., Peet, G. W., Warren, T. C., Capolino, A., Mara, L., Morelock, M. M., Shrutkowski, A., Jones, J. W., and Pargellis, C. A. (2009) Inhibition of pro-inflammatory cytokine production by the dual p38/JNK2 inhibitor BIRB796 correlates with the inhibition of p38 signaling Biochem. Pharmacol. 77, 422-432 10.1016/j.bcp.2008.10.032
31. Lauffer, B. E., Mintzer, R., Fong, R., Mukund, S., Tam, C., Zilberleyb, I., Flicke, B., Ritscher, A., Fedorowicz, G., Vallero, R., Ortwine, D. F., Gunzner, J., Modrusan, Z., Neumann, L., Koth, C. M., Lupardus, P. J., Kaminker, J. S., Heise, C. E., and Steiner, P. (2013) Histone deacetylase (HDAC) inhibitor kinetic rate constants correlate with cellular histone acetylation but not transcription and cell viability J. Biol. Chem. 288, 26926-26943 10.1074/jbc.M113.490706
32. Makkonen, K. M., Malinen, M., Ropponen, A., Vaisanen, S., and Carlberg, C. (2009) Cell cycle regulatory effects of retinoic Acid and forskolin are mediated by the cyclin C gene J. Mol. Biol. 393, 261-271 10.1016/j.jmb.2009.08.024
33. Machleidt, T., Woodroofe, C. C., Schwinn, M. K., Méndez, J., Robers, M. B., Zimmerman, K., Otto, P., Daniels, D. L., Kirkland, T. A., and Wood, K. V. (2015) NanoBRET-a Novel BRET Platform for the Analysis of Protein-Protein Interactions ACS Chem. Biol. 150609142923008 10.1021/acschembio.5b00143
34. Cheng, Y. and Prusoff, W. H. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction Biochem. Pharmacol. 22, 3099-3108 10.1016/0006-2952(73)90196-2
35. Zhuo, D. X., Zhang, X. W., Jin, B., Zhang, Z., Xie, B. S., Wu, C. L., Gong, K., and Mao, Z. B. (2013) CSTP1, a novel protein phosphatase, blocks cell cycle, promotes cell apoptosis, and suppresses tumor growth of bladder cancer by directly dephosphorylating Akt at Ser473 site PLoS One 8, e65679 10.1371/journal.pone.0065679
36. Dominy, J. E., Jr., Simmons, C. R., Hirschberger, L. L., Hwang, J., Coloso, R. M., and Stipanuk, M. H. (2007) Discovery and characterization of a second mammalian thiol dioxygenase, cysteamine dioxygenase J. Biol. Chem. 282, 25189-25198 10.1074/jbc.M703089200
37. Bantscheff, M., Hopf, C., Savitski, M. M., Dittmann, A., Grandi, P., Michon, A. M., Schlegl, J., Abraham, Y., Becher, I., Bergamini, G., Boesche, M., Delling, M., Dumpelfeld, B., Eberhard, D., Huthmacher, C., Mathieson, T., Poeckel, D., Reader, V., Strunk, K., Sweetman, G., Kruse, U., Neubauer, G., Ramsden, N. G., and Drewes, G. (2011) Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes Nat. Biotechnol. 29, 255-265 10.1038/nbt.1759
38. Fischer, J. J., Michaelis, S., Schrey, A. K., Diehl, A., Graebner, O. Y., Ungewiss, J., Horzowski, S., Glinski, M., Kroll, F., Dreger, M., and Koester, H. (2011) SAHA Capture Compound - a novel tool for the profiling of histone deacetylases and the identification of additional vorinostat binders Proteomics 11, 4096-4104 10.1002/pmic.201000717
39. Tenneze, L., Daurat, V., Tibi, A., Chaumet-Riffaud, P., and Funck-Brentano, C. (1999) A study of the relative bioavailability of cysteamine hydrochloride, cysteamine bitartrate and phosphocysteamine in healthy adult male volunteers Br. J. Clin. Pharmacol. 47, 49-52 10.1046/j.1365-2125.1999.00844.x
40. Karpuj, M. V., Becher, M. W., Springer, J. E., Chabas, D., Youssef, S., Pedotti, R., Mitchell, D., and Steinman, L. (2002) Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine Nat. Med. 8, 143-149 10.1038/nm0202-143